269 related articles for article (PubMed ID: 16807410)
1. For sale: physicians' prescribing data.
Steinbrook R
N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410
[No Abstract] [Full Text] [Related]
2. The physician payment sunshine act is here--are you ready?
Lazarus JA
J Miss State Med Assoc; 2013 Jun; 54(6):177. PubMed ID: 23991517
[No Abstract] [Full Text] [Related]
3. Sale of Canadian doctors' drug data goes to court.
Kondro W
Lancet; 2003 Sep; 362(9387):884. PubMed ID: 13679000
[No Abstract] [Full Text] [Related]
4. Doctors object as drug makers learn who's prescribing what.
Saul S
N Y Times Web; 2006 May; ():A1, C4. PubMed ID: 16718959
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
6. Commercial versus social goals of tracking what doctors do.
Grande D; Asch DA
N Engl J Med; 2009 Feb; 360(8):747-9. PubMed ID: 19228616
[No Abstract] [Full Text] [Related]
7. Higher First Amendment hurdles for public health regulation.
Outterson K
N Engl J Med; 2011 Aug; 365(7):e13. PubMed ID: 21812665
[No Abstract] [Full Text] [Related]
8. Big pharma often commits corporate crime, and this must be stopped.
Gøtzsche PC
BMJ; 2012 Dec; 345():e8462. PubMed ID: 23241451
[No Abstract] [Full Text] [Related]
9. Study affirms PhRMA's influence on physicians.
Miller JD
J Natl Cancer Inst; 2007 Aug; 99(15):1148-50. PubMed ID: 17652272
[No Abstract] [Full Text] [Related]
10. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
Roehr B
BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
[No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: cost savings. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
[No Abstract] [Full Text] [Related]
12. Alberta delivers new blow to prescription data mining.
Dunleavy N
CMAJ; 2003 Apr; 168(9):1169. PubMed ID: 12719332
[No Abstract] [Full Text] [Related]
13. Why States should ban the sale of physician prescribing data.
Schaefer BM; Rising J; Grande D; Silver-Isenstadt J;
J Ambul Care Manage; 2007; 30(3):206-8. PubMed ID: 17581431
[No Abstract] [Full Text] [Related]
14. Statement of principles: the sale and use of data on individual physicians' prescribing. Canadian Medical Association.
CMAJ; 1997 Feb; 156(3):424A-424D. PubMed ID: 9033430
[TBL] [Abstract][Full Text] [Related]
15. Can state medical boards adequately respond to reports that physicians are inappropriately prescribing opioids?
Hoffmann DE
Clin Pharmacol Ther; 2007 Jun; 81(6):799-801. PubMed ID: 17505493
[TBL] [Abstract][Full Text] [Related]
16. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
17. Physician specific prescribing information.
Somberg J
Am J Ther; 2006; 13(6):465. PubMed ID: 17122524
[No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
Jones TM
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
[No Abstract] [Full Text] [Related]
19. Prescriptions, privacy, and the First Amendment.
Curfman GD; Morrissey S; Drazen JM
N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208
[No Abstract] [Full Text] [Related]
20. Physician payment disclosure under health care reform: will the sun shine?
Mackey TK; Liang BA
J Am Board Fam Med; 2013; 26(3):327-31. PubMed ID: 23657702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
